Skip to content
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
BioTechGrid BioTechGrid
  • Home
  • Biotechnology
  • Medical Technology
  • Research
  • Genetics
  • Press Releases
    • Business Wire
    • GlobeNewswire
    • PRNewswire
  • Contact
  • Home
  • 2026
  • June
  • Page 119
macrocyclic-peptide-drugs-unlocked,-membrane-permeability-screened-at-scale
Posted inGenetics

Macrocyclic Peptide Drugs Unlocked, Membrane Permeability Screened at Scale

June 1, 2026
Membrane-permeable cyclic peptide that inhibits the intracellular Keap1-Nrf2 protein-protein interaction. [Christian Heinis (EPFL)] Macrocyclic peptides are a promising drug modality that combine the oral convenience…
Read More
Posted inBiotechnology

How integrated strategy is reshaping biopharma growth

June 1, 2026
As biopharma organizations face growing complexity, integrated operating models are becoming a strategic advantage. In this interview, RevHealth CEO Ben…
Read More
asco:-bristol-myers’-$800m-bispecific-adc-aces-china-breast-cancer-study,-putting-trop2-drugs-on-notice
Posted inBiotechnology

ASCO: Bristol Myers’ $800M bispecific ADC aces China breast cancer study, putting TROP2 drugs on notice

June 1, 2026
A first-in-class bispecific antibody-drug conjugate that Bristol Myers Squibb paid $800 million for has shown strong phase 3 results from…
Read More
Posted inGenetics

Multiomics Mass Spec Workflows in Drug Discovery

June 1, 2026
Credit: Jose A. Bernat Bacete / Getty Images Advances in end-to-end multiomics platforms and the underlying scientific knowledge now enable…
Read More
asco,-ryght-ai-team-up-for-breast-cancer-trial-site-selection
Posted inResearch

ASCO, Ryght AI team up for breast cancer trial site selection

June 1, 2026
The American Society of Clinical Oncology (ASCO) and Ryght AI are teaming up to identify research sites for an ASCO…
Read More
illuminating-the-drug-development-path-with-cell-based-reporter-assays
Posted inGenetics

Illuminating the Drug Development Path with Cell-Based Reporter Assays

June 1, 2026
Sponsored content brought to you by Selecting and advancing drug candidates through discovery and development is a long, resource-intensive process.…
Read More
one-antibody,-fewer-scientific-surprises
Posted inGenetics

One Antibody, Fewer Scientific Surprises

June 1, 2026
Sponsored content brought to you by In biomedical research, promising programs rarely collapse for lack of scientific ambition. More often,…
Read More
from-discovery-to-development-in-emerging-modalities
Posted inGenetics

From Discovery to Development in Emerging Modalities

June 1, 2026
Sponsored content brought to you by The world of biologics is moving far beyond traditional monoclonal antibodies, and companies across…
Read More
rallybio-swerves-past-candid-pothole-to-land-deal-with-cancer-drug-developer-avenzo
Posted inBiotechnology

Rallybio swerves past Candid pothole to land deal with cancer drug developer Avenzo

June 1, 2026
Rallybio has steered its way to a new reverse merger, inking a deal with Avenzo Therapeutics weeks after a UCB buyout…
Read More
agios-signs-$165m-deal-for-blood-disorder-drug-from-korea’s-oscotec-that-flunked-phase-2-study
Posted inBiotechnology

Agios signs $165M deal for blood disorder drug from Korea’s Oscotec that flunked phase 2 study

June 1, 2026
Days after its lead clinical-stage drug suffered a setback, Agios Pharmaceuticals has rebounded by buying a blood disorder drug that…
Read More

Posts pagination

Previous page 1 … 117 118 119 120 Next page

Privacy Policy    Terms

Scroll to Top